1. Home
  2. AUDC vs BNTC Comparison

AUDC vs BNTC Comparison

Compare AUDC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.84

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.50

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
BNTC
Founded
1992
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
405.7M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AUDC
BNTC
Price
$8.84
$13.50
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$11.67
$27.67
AVG Volume (30 Days)
92.1K
245.8K
Earning Date
02-03-2026
02-13-2026
Dividend Yield
4.48%
N/A
EPS Growth
15.76
N/A
EPS
0.46
N/A
Revenue
$244,553,000.00
N/A
Revenue This Year
$2.98
N/A
Revenue Next Year
$3.40
N/A
P/E Ratio
$19.19
N/A
Revenue Growth
0.15
N/A
52 Week Low
$8.01
$9.70
52 Week High
$12.72
$17.15

Technical Indicators

Market Signals
Indicator
AUDC
BNTC
Relative Strength Index (RSI) 46.09 55.22
Support Level $8.79 $10.99
Resistance Level $8.96 $13.36
Average True Range (ATR) 0.22 0.93
MACD 0.00 0.20
Stochastic Oscillator 12.52 94.82

Price Performance

Historical Comparison
AUDC
BNTC

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: